144 related articles for article (PubMed ID: 37839992)
1. Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.
Tibarewal P; Spinelli L; Maccario H; Leslie NR
Adv Biol Regul; 2024 Jan; 91():100989. PubMed ID: 37839992
[TBL] [Abstract][Full Text] [Related]
2. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
[TBL] [Abstract][Full Text] [Related]
3. PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13.
Sotelo NS; Schepens JT; Valiente M; Hendriks WJ; Pulido R
Methods; 2015 May; 77-78():147-56. PubMed ID: 25448478
[TBL] [Abstract][Full Text] [Related]
4. Protein interactions of phosphatase and tensin homologue (PTEN) and its cancer-associated G20E mutant compared by using stable isotope labeling by amino acids in cell culture-based parallel affinity purification.
Gunaratne J; Goh MX; Swa HL; Lee FY; Sanford E; Wong LM; Hogue KA; Blackstock WP; Okumura K
J Biol Chem; 2011 May; 286(20):18093-103. PubMed ID: 21454687
[TBL] [Abstract][Full Text] [Related]
5. A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer.
Herlevsen M; Oxford G; Ptak C; Shabanowitz J; Hunt DF; Conaway M; Theodorescu D
Biochem Biophys Res Commun; 2007 Jan; 352(2):549-55. PubMed ID: 17126809
[TBL] [Abstract][Full Text] [Related]
6. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
7. TNPO3-Mediated Nuclear Entry of the Rous Sarcoma Virus Gag Protein Is Independent of the Cargo-Binding Domain.
Rice BL; Stake MS; Parent LJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581109
[TBL] [Abstract][Full Text] [Related]
8. PTEN: a novel anti-oncogenic function independent of phosphatase activity.
Okumura K; Zhao M; DePinho RA; Furnari FB; Cavenee WK
Cell Cycle; 2005 Apr; 4(4):540-2. PubMed ID: 15753657
[TBL] [Abstract][Full Text] [Related]
9. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
Wu X; Hepner K; Castelino-Prabhu S; Do D; Kaye MB; Yuan XJ; Wood J; Ross C; Sawyers CL; Whang YE
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4233-8. PubMed ID: 10760291
[TBL] [Abstract][Full Text] [Related]
10. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R
J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Investigating the Protein Interactome of PTEN.
Smith SL; Pitt AR; Spickett CM
J Proteome Res; 2021 Jan; 20(1):60-77. PubMed ID: 33074689
[TBL] [Abstract][Full Text] [Related]
12. Assaying PTEN catalysis in vitro.
Spinelli L; Leslie NR
Methods; 2015 May; 77-78():51-7. PubMed ID: 25461809
[TBL] [Abstract][Full Text] [Related]
13. A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains.
Sotelo NS; Valiente M; Gil A; Pulido R
J Cell Biochem; 2012 Aug; 113(8):2661-70. PubMed ID: 22434720
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4.
Gorbenko O; Panayotou G; Zhyvoloup A; Volkova D; Gout I; Filonenko V
Mol Cell Biochem; 2010 Apr; 337(1-2):299-305. PubMed ID: 19911253
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the PTEN phosphatase.
Gericke A; Munson M; Ross AH
Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
[TBL] [Abstract][Full Text] [Related]
16. PTEN loss in the continuum of common cancers, rare syndromes and mouse models.
Hollander MC; Blumenthal GM; Dennis PA
Nat Rev Cancer; 2011 Apr; 11(4):289-301. PubMed ID: 21430697
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of PTEN loss in cancer: It's all about diversity.
Álvarez-Garcia V; Tawil Y; Wise HM; Leslie NR
Semin Cancer Biol; 2019 Dec; 59():66-79. PubMed ID: 30738865
[TBL] [Abstract][Full Text] [Related]
18. Importin-11 keeps PTEN safe from harm.
Leslie NR
J Cell Biol; 2017 Mar; 216(3):539-541. PubMed ID: 28193699
[TBL] [Abstract][Full Text] [Related]
19. Yeast-based methods to assess PTEN phosphoinositide phosphatase activity in vivo.
Rodríguez-Escudero I; Fernández-Acero T; Bravo I; Leslie NR; Pulido R; Molina M; Cid VJ
Methods; 2015 May; 77-78():172-9. PubMed ID: 25448481
[TBL] [Abstract][Full Text] [Related]
20. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.
Chen M; Nowak DG; Narula N; Robinson B; Watrud K; Ambrico A; Herzka TM; Zeeman ME; Minderer M; Zheng W; Ebbesen SH; Plafker KS; Stahlhut C; Wang VM; Wills L; Nasar A; Castillo-Martin M; Cordon-Cardo C; Wilkinson JE; Powers S; Sordella R; Altorki NK; Mittal V; Stiles BM; Plafker SM; Trotman LC
J Cell Biol; 2017 Mar; 216(3):641-656. PubMed ID: 28193700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
